Compare · HLN vs SLSN
HLN vs SLSN
Side-by-side comparison of Haleon plc (HLN) and Solesence Inc. (SLSN): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both HLN and SLSN operate in Package Goods/Cosmetics (Consumer Discretionary), so they compete in similar markets.
- HLN is the larger of the two at $44.18B, about 811.2x SLSN ($54.5M).
- Over the past year, HLN is up 2.9% and SLSN is down 83.2% - HLN leads by 86.1 points.
- HLN has been more active in the news (4 items in the past 4 weeks vs 2 for SLSN).
- HLN has more recent analyst coverage (19 ratings vs 0 for SLSN).
- Company
- Haleon plc
- Solesence Inc.
- Price
- $9.93-1.24%
- $0.75+0.00%
- Market cap
- $44.18B
- $54.5M
- 1M return
- +10.65%
- -44.65%
- 1Y return
- +2.90%
- -83.18%
- Industry
- Package Goods/Cosmetics
- Package Goods/Cosmetics
- Exchange
- NYSE
- NASDAQ
- IPO
- 2022
- News (4w)
- 4
- 2
- Recent ratings
- 19
- 0
Haleon plc
Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. Its portfolio of brands include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was incorporated in 2021 and is headquartered in Brentford, the United Kingdom. Haleon plc(LSE:HLN) operates independently of GSK plc as of July 18, 2022.
Latest HLN
- SEC Form 6-K filed by Haleon plc
- SEC Form 6-K filed by Haleon plc
- Haleon to Accelerate AI-powered Transformation With New Five-year Microsoft Collaboration
- SEC Form 6-K filed by Haleon plc
- One in Three Western Consumers Now Buy Products Discovered on Social Platforms as AI Reshapes Commerce, According to NIQ
- SEC Form 6-K filed by Haleon plc
- SEC Form 6-K filed by Haleon plc
- Advil Challenges Sports Culture's "No Pain No Gain" Mentality This Summer
- SEC Form 6-K filed by Haleon plc
- Haleon Invests in India to Deliver Better Everyday Health to Rural Communities
Latest SLSN
- Solésence Brings Patent-Backed Skin Health Innovation to Hair and Scalp
- Solesence Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits
- Solésence Named Contract Manufacturing Partner of the Year in the 2026 Cosmetics Business Innovation Awards
- Solésence Day Mode Hero Concealer SPF 50+ Wins Three Categories at the 2026 Cosmetics & Toiletries Allē Awards, Marking Fourth Year of Recognition
- Solésence Supports Landmark Report on UV Safety in the United Kingdom as Member of UV Safety Coalition
- SEC Form 10-Q filed by Solesence Inc.
- Solesence Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Solésence Reports First Quarter 2026 Financial Results
- Solésence Launches New Skin Health Technologies: WHSPR™ and Chromalüm™
- Solesence Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits